1st Sep 2016 7:00 am |
RNS |
AstraZeneca Completes Aspen Agreement |
24th Aug 2016 7:00 am |
RNS |
AZ TO SELL ANTIBIOTICS BUSINESS TO PFIZER |
18th Aug 2016 1:00 pm |
RNS |
Director Declaration |
16th Aug 2016 7:00 am |
RNS |
AstraZeneca completes agreement with LEO Pharma |
10th Aug 2016 2:41 pm |
RNS |
ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA |
9th Aug 2016 7:00 am |
RNS |
ASTRAZENECA UPDATE ON SELUMETINIB PHASE III TRIAL |
1st Aug 2016 2:30 pm |
RNS |
Total Voting Rights |
1st Aug 2016 11:00 am |
RNS |
Director/PDMR Shareholding |
28th Jul 2016 7:00 am |
RNS |
AZN: H1 2016 Results |
27th Jul 2016 9:00 am |
RNS |
Notice of Results |
19th Jul 2016 2:15 pm |
RNS |
QTERN (saxa/dapa) EU approved for type-2 diabetes |
18th Jul 2016 7:00 am |
RNS |
TAGRISSO MET PRIMARY ENDPOINT IN PHASE III TRIAL |
14th Jul 2016 12:07 pm |
RNS |
Second Price Monitoring Extn |
14th Jul 2016 12:02 pm |
RNS |
Price Monitoring Extension |
13th Jul 2016 7:00 am |
RNS |
AZ resolves Faslodex patent litigation in the US |
1st Jul 2016 5:30 pm |
RNS |
Total Voting Rights |
28th Jun 2016 7:00 am |
RNS |
Zavicefta approved in EU |
23rd Jun 2016 7:00 am |
RNS |
AstraZeneca updates on Flumist vaccine in the US |
14th Jun 2016 3:00 pm |
RNS |
Director/PDMR Shareholding |
9th Jun 2016 7:03 am |
RNS |
AZ agreement with Aspen for anaesthetics portfolio |
3rd Jun 2016 7:00 am |
RNS |
AZ completes US licensing agreement with Ironwood |
2nd Jun 2016 7:00 am |
RNS |
AZ LICENSES ZURAMPIC TO GRÜNENTHAL GMBH |
1st Jun 2016 12:00 pm |
RNS |
Block listing Interim Review |
1st Jun 2016 11:30 am |
RNS |
Total Voting Rights |
27th May 2016 12:36 pm |
RNS |
POSITIVE CHMP OPINION IN EU FOR SAXA/DAPA |
27th May 2016 7:03 am |
RNS |
Positive results from AstraZeneca Faslodex trial |
27th May 2016 7:00 am |
RNS |
AstraZeneca receives CRL from US FDA for ZS-9 |
23rd May 2016 4:00 pm |
RNS |
Director/PDMR Shareholding |
18th May 2016 7:00 am |
RNS |
TOP-LINE RESULTS FROM LYNPARZA GOLD TRIAL |
17th May 2016 7:00 am |
RNS |
POSITIVE BENRALIZUMAB RESULTS IN SEVERE ASTHMA |
12th May 2016 7:00 am |
RNS |
SELUMETINIB GRANTED ORPHAN DRUG DESIGNATION IN US |
11th May 2016 5:30 pm |
RNS |
Publication of Final Terms |
9th May 2016 5:35 pm |
RNS |
Launch and pricing of EUR2.2bn bond issues |
5th May 2016 3:00 pm |
RNS |
Publication of a Prospectus |
3rd May 2016 1:30 pm |
RNS |
Total Voting Rights |
3rd May 2016 7:01 am |
RNS |
AstraZeneca completes divestment of Imdur |
3rd May 2016 7:00 am |
RNS |
AZ COMPLETES ACQUISITION OF TAKEDA RESPIRATORY |
29th Apr 2016 5:30 pm |
RNS |
Result of AGM |
29th Apr 2016 12:46 pm |
RNS |
POSITIVE CHMP OPINION FOR CAZ AVI |
29th Apr 2016 7:00 am |
RNS |
AZN: 1st Quarter Results |